Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...
Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...
Research Site, Rouffach, France
University of Missouri - Columbia dept. of Emergency Medicine, Columbia, Missouri, United States
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Tel Aviv Medical Center, Tel Aviv, Israel
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States
Research Site, Oxford, United Kingdom
Seoul National University Hospital, Seoul, Korea, Republic of
University of North Carolina School of Dentistry, Chapel Hill, North Carolina, United States
Hennepin County Medical Center, Minneapolis, Minnesota, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.